TEGENS 20CPS 160MG

TEGENS

active ingredients

TEGENS 160 mg rigid capsules: Each capsule contains: Active ingredient: anthocyanide complex of cranberry to 36% of anthocyids (Myrtocyan) 160 mg. TEGENS 160 mg granulated oral solution: Each bag contains: Active ingredient: anthocyanide complex of cranberry to 36% of anthocyids (Myrtocyan) 160 mg. Excipient(s) with known effects: a capsule contains 20 mg lactose. A bag contains 15 mg lactose. For the full list of excipients, see paragraph 6.1.

Excellent

Hard capsules: mannitolo, lactose, methylcellulose, citric acid, precipitated silica, magnesium stearate, gelatin (excipient of the envelope). Granulated oral solution: mannitolo, lactose monohydrate, methylcellulose, citric acid anidro, blueberry aroma, glycirrizate ammonium.

Therapeutic indications

Symptoms attributable to venous failure; states of capillary fragility.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.

Population

Population ADULTS: granulate capsules or bags: 1-2 a day. It is appropriate to take this medicine in the morning and in the evening, with intervals of 12-24 hours. Do not exceed the recommended doses. Pediatric population The use of the product is reserved for adults. Method of administration The granulate, to be taken as such or dissolved in little water, is recommended in subjects with difficulty of swallowing and under conditions of irritability of the gastric mucosa from gastric-ulcerosis processes.

Conservation

Hard capsules: Store at temperature not exceeding 30°C. Granulated oral solution: no special precaution for conservation.

Warnings

As with all symptomatic treatments, it is necessary to contact your doctor if the symptoms did not improve after a short period of treatment. Clinical use did not highlight the need for particular cautels for the use of the drug. This medicine contains lactose: patients with rare hereditary problems of galactose intolerance, lactase deficiency, or glucosegalactose mal absorption, should not take this medicine. Pediatric population The use of the product is reserved for adults.

Interactions

There have never been reported phenomena related to interactions with other substances.

Effects

TEGENS has excellent tolerance. Rare cases of gastrointestinal disorders have been reported, such as heartburn, nausea and a sense of gastric heaviness, and skin rashes.Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at: http://www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No overdose cases have been reported.

Pregnancy

The safety of the drug during pregnancy has not been determined, therefore it is appropriate not to administer the product during pregnancy.

Food

In breastfeeding, the product must be used in cases of actual need under the direct control of the doctor.

Source: Farmadati